Supervised pelvic floor muscle training improves sexual function and diminishes sexual distress in women with multiple sclerosis

INTERVENTION: The intervention included women suffering from MS with an EDSS score <4 and divided them into two groups. In Group A, women followed a program of supervised pelvic floor muscle training (PFMT) for 12 weeks, and women in Group B comprised the control group. The total duration of the intervention was 12 weeks. At the beginning and end of the study, all women completed the FSFI and FSDS‐R questionnaires to assess their sexual function/distress and evaluate if there were any differences between the two groups. 1. Method of randomization. Women were consecutively randomized into the two groups. Consecutive sampling is a non‐probability sampling technique where samples are picked at the ease of the investigator, more like convenient sampling. In that way, we produced two groups with an equal number of women. 2. The principal investigator, doctor, and physiotherapist evaluated the pelvic floor to provide evidence that the woman could perform pelvic floor muscle exercises. All work in the rehabilitation center and are members of the pelvic floor unit. They already have the necessary specific training and are all considered specialists in their topic. 3. The instruction of the PFMT was face‐to‐face, but during the study period, there were a lot of telephone communications to strengthen our patients and increase adherence to the program. 4. All the necessary interventions occurred on the premises of Kentavros Rehabilitation Center. CONDITION: Supervised pelvic floor muscle training improves sexual function and diminishes sexual distress in women with multiple sclerosis ; Musculoskeletal Diseases PRIMARY OUTCOME: Effect of pelvic floor muscle training (PFMT) on improving sexual function and sexual distress in women suffering from MS measured using the Female Sexual Function Index (FSFI) and the Female Sexual Distress Scale‐Revised (FSDS‐R) questionnaires scores at the beginning and end of the twelve‐week study; SECONDARY OUTCOME: There are no secondary outcome measures INCLUSION CRITERIA: 1. 18 years of age or older 2. Diagnosis of relapsing‐remitting MS 3. Stable condition for a minimum period of si Xmonths 4. Kurtzke’s Expanded Disability Status Scale (EDSS) score < 4 5. Women sexually active for at least four weeks 6. Cognitive ability to complete the questionnaires and study protocol 7. Ability to contract PFM evaluated by the primary investigator